ISDA

Deposition Date 2006-08-17

Release Date 2006-09-27

Last Version Date 2024-11-20

Entry Detail

PDB ID:

2J2U

Keywords:

HYDROLASE

Title:

CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.90 Å

R-Value Free:

0.23

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:COAGULATION FACTOR X HEAVY CHAIN
Gene (Uniprot):F10
Chain IDs:A
Chain Length:254
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Protein Blast

Polymer Type:polypeptide(L)
Molecule:COAGULATION FACTOR X LIGHT CHAIN
Gene (Uniprot):F10
Chain IDs:B
Chain Length:134
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P00742 Pfam ID:PF00089, PF00594, PF00008, PF14670 EC:3.4.21.6

Ligand Molecules

GSQ

Primary Citation

Arylsulfonamides: A Study of the Relationship between Activity and Conformational Preferences for a Series of Factor Xa Inhibitors.

Senger, S, Convery, M.A, Chan, C, Watson, N.S.Show

Bioorg.Med.Chem.Lett. 16 5731 ? (2006)

PMID: 16982192 DOI: 10.1016/J.BMCL.2006.08.092

Abstact

Torsional scans of sulfonamide S-C bonds in small model systems of a series of arylsulfonamide factor Xa inhibitors were performed in order to investigate if conformational effects can help to rationalise the observed SAR. Computational results were in good agreement with the experimental data indicating that the sulfonamide conformation plays an important role in determining the activity in this particular series of factor Xa inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures